Compare
Cannaisseur Group Inc. vs Natural Alternatives International Inc vs C21 Investments Inc. vs USANA Health Sciences Inc
| Latest fiscal year | Cannaisseur Group Inc. TCRG | Natural Alternatives International Inc NAII | C21 Investments Inc. CWLXF | USANA Health Sciences Inc USNA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-06-30 | 2026-03-31 | 2026-01-03 |
| Revenue | $0 | $142.51M | $32.61M | $925.26M |
| Revenue growth (YoY) | -100.0% | +9.7% | +8.3% | +8.3% |
| Gross margin | n/a | 6.3% | 41.7% | 78.3% |
| Operating margin | n/a | -13.2% | 7.0% | 4.0% |
| Net margin | n/a | -14.5% | -9.9% | 1.2% |
| Net income | -$1.77M | -$20.70M | -$3.24M | $10.76M |
| EPS (Diluted) | -$0.03 | -$3.43 | -$0.03 | $0.58 |
| Operating cash flow | -$127.5K | -$8.92M | $1.36M | $22.35M |
| Free cash flow | n/a | -$12.62M | $1.12M | $8.53M |
| Cash & equivalents | $22 | $7.39M | n/a | $158.38M |
| Total assets | $140 | $126.45M | $54.42M | $742.91M |
| Total liabilities | $235.4K | $76.49M | $28.99M | $156.64M |
| Shareholders' equity | -$235.3K | $49.96M | $25.43M | $533.10M |
| Return on year-end equity | n/a | -41.4% | -12.8% | 2.0% |
| Shares outstanding | 60.46M | 6.27M | 117.84M | 18.28M |
Revenue, most recent five fiscal years
| Fiscal year | Cannaisseur Group Inc. | Natural Alternatives International Inc | C21 Investments Inc. | USANA Health Sciences Inc |
|---|---|---|---|---|
| Latest | $0 Ended 2025-12-31 | $142.51M Ended 2026-06-30 | $32.61M Ended 2026-03-31 | $925.26M Ended 2026-01-03 |
| 1 year earlier | $700 Ended 2024-12-31 | $129.86M Ended 2025-06-30 | $30.12M Ended 2025-03-31 | $854.50M Ended 2024-12-28 |
| 2 years earlier | $53.1K Ended 2023-12-31 | $113.80M Ended 2024-06-30 | n/a | $921.01M Ended 2023-12-30 |
| 3 years earlier | $88.1K Ended 2022-12-31 | $154.01M Ended 2023-06-30 | n/a | $998.60M Ended 2022-12-31 |
| 4 years earlier | n/a | $170.97M Ended 2022-06-30 | n/a | $1.19B Ended 2022-01-01 |